- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03796117
Pulsed Current Versus Russian Current Effects in Healthy Young Subjects.
Neuromuscular Parameters, Current Intensity and Discomfort Level Between Pulsed Current and Russian Current in Healthy Young Subjects.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Rio Grande Do Sul
-
Porto Alegre, Rio Grande Do Sul, Brazil, 90690-200
- Exercise Research Laboratory, School of Physical Education, Federal University of Rio Grande do Sul
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Young male
- Age between 18 and 35 years
- Physically active,
- Normal knee function and range of motion
- No pain complaints
- No presence of lower limb pathology at the dominant limb.
Exclusion Criteria:
- Health problems (neurological, musculoskeletal impairment),
- Contraindication to maximal exercise,
- Having been treated with NMES in the last 3 months in the lower limb
- Not meeting the inclusion criteria.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Group 1: healthy young
Participants receive two interventions (Pulsed Current - PC, or Russian Current - RC) in a specific order, according to randomization.
Evoked torque, discomfort level, current intensity, neuromuscular efficiency, clinical efficiency and fatigability level will be evaluated.
|
For stage 1 of the study, which corresponds to analysis of the evoked torque, evaluation of the discomfort level, current intensity, analysis of neuromuscular efficiency and clinical efficiency, 2 configurations (PC1 and PC2) will be used. PC1, will be set at a frequency of 100 Hz, phase duration of 1000 microseconds, ON-OFF time of 5s:10s. PC2, will be set at a frequency of 100 Hz, phase duration of 200 microseconds ON-OFF time of 5s:10s. For stage 2 of the study, which corresponds to the analysis of the fatigability level, only the PC1 configuration will be used. For stage 1 of the study, which corresponds to analysis of the evoked torque, discomfort level, current intensity, neuromuscular efficiency and clinical efficiency, 2 configurations (RC1 and RC2) will be used. RC1, will be set to a frequency of 100 Hz, burst duty cycle of 20%, ON-OFF time of 5s:10s. RC2, will be set at a frequency of 100 Hz, burst duty cycle of 50%, ON-OFF time of 5s:10s. For stage 2 of the study, which corresponds to the analysis of the fatigability level, only the RC2 configuration will be used. |
|
Experimental: Experimental Group 2: healthy young
Participants receive two interventions (Pulsed Current - PC, or Russian Current - RC) in a specific order, according to randomization.
Evoked torque, discomfort level, current intensity, neuromuscular efficiency, clinical efficiency and fatigability level will be evaluated.
|
For stage 1 of the study, which corresponds to analysis of the evoked torque, evaluation of the discomfort level, current intensity, analysis of neuromuscular efficiency and clinical efficiency, 2 configurations (PC1 and PC2) will be used. PC1, will be set at a frequency of 100 Hz, phase duration of 1000 microseconds, ON-OFF time of 5s:10s. PC2, will be set at a frequency of 100 Hz, phase duration of 200 microseconds ON-OFF time of 5s:10s. For stage 2 of the study, which corresponds to the analysis of the fatigability level, only the PC1 configuration will be used. For stage 1 of the study, which corresponds to analysis of the evoked torque, discomfort level, current intensity, neuromuscular efficiency and clinical efficiency, 2 configurations (RC1 and RC2) will be used. RC1, will be set to a frequency of 100 Hz, burst duty cycle of 20%, ON-OFF time of 5s:10s. RC2, will be set at a frequency of 100 Hz, burst duty cycle of 50%, ON-OFF time of 5s:10s. For stage 2 of the study, which corresponds to the analysis of the fatigability level, only the RC2 configuration will be used. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximum voluntary isometric contraction of the knee extensors
Time Frame: 14 minutes
|
is an expression of the muscular strength, and will be evaluated by dynamometry.
|
14 minutes
|
|
Knee extensors evoked torque during the tests at submaximal current intensity levels
Time Frame: During 90 seconds of electrical stimulation
|
is an expression describing the muscular strength generated by electrical stimulation, and will be assessed by dynamometry.
|
During 90 seconds of electrical stimulation
|
|
Knee extensors evoked torque during the tests at maximal current intensity levels
Time Frame: During 90 seconds of electrical stimulation
|
is an expression describing the muscular strength generated by electrical stimulation, and will be assessed by dynamometry.
|
During 90 seconds of electrical stimulation
|
|
Knee extensors evoked torque during the fatigue protocol
Time Frame: During 20 minutes of electrical stimulation
|
is an expression describing the muscular strength generated by electrical stimulation, and will be assessed by dynamometry.
|
During 20 minutes of electrical stimulation
|
|
Muscular architecture during the knee extensors maximum voluntary isometric contraction tests
Time Frame: 14 minutes
|
is an expression used to describe the muscle fibers arrangement within the muscle, and is evaluated by determining the muscle thickness, fascicle pennation angle and fascicle length, which will be assessed by ultrasonography.
|
14 minutes
|
|
Muscular architecture during knee extensors evoked torque tests at submaximal current intensity levels
Time Frame: During 90 seconds of electrical stimulation
|
is an expression used to describe the muscle fibers arrangement within the muscle, and is evaluated by determining the muscle thickness, fascicle pennation angle and fascicle length, which will be assessed by ultrasonography.
|
During 90 seconds of electrical stimulation
|
|
Muscular architecture during knee extensors evoked torque tests at maximal current intensity levels
Time Frame: During 90 seconds of electrical stimulation
|
is an expression used to describe the muscle fibers arrangement within the muscle, and is evaluated by determining the muscle thickness, fascicle pennation angle and fascicle length, which will be assessed by ultrasonography.
|
During 90 seconds of electrical stimulation
|
|
Muscular architecture during the fatigue protocol
Time Frame: During 20 minutes of electrical stimulation
|
is an expression used to describe the muscle fibers arrangement within the muscle, and is evaluated by determining the muscle thickness, fascicle pennation angle and fascicle length, which will be assessed by ultrasonography.
|
During 20 minutes of electrical stimulation
|
|
Discomfort level generated by electrical stimulation during evoked torque tests at submaximal current intensity levels
Time Frame: During 90 seconds of electrical stimulation
|
Discomfort will be measured with a Visual Analogue Scale (0-100mm), where 0 and 100 mm corresponded to no discomfort and worst perceived discomfort, respectively.
|
During 90 seconds of electrical stimulation
|
|
Discomfort level generated by electrical stimulation during evoked torque tests at maximal current intensity levels
Time Frame: During 90 seconds of electrical stimulation
|
Discomfort will be measured with a Visual Analogue Scale (0-100mm), where 0 and 100 mm corresponded to no discomfort and worst perceived discomfort, respectively.
|
During 90 seconds of electrical stimulation
|
|
Discomfort level generated by electrical stimulation during the fatigue protocol
Time Frame: During 20 minutes of electrical stimulation
|
Discomfort will be measured with a Visual Analogue Scale (0-100mm), where 0 and 100 mm corresponded to no discomfort and worst perceived discomfort, respectively.
|
During 20 minutes of electrical stimulation
|
|
Current intensity required to evoke knee extensors submaximal torque
Time Frame: During 90 seconds of electrical stimulation
|
Current intensity is defined as the amount or amplitude of electrical current (in milliamperes - mA) required to achieve a specific force, and will be evaluated in the electrical stimulation device.
|
During 90 seconds of electrical stimulation
|
|
Current intensity required to evoke knee extensors maximal torque
Time Frame: During 90 seconds of electrical stimulation
|
Current intensity is defined as the amount or amplitude of electrical current (in milliamperes - mA) required to achieve a specific force, and will be evaluated in the electrical stimulation device.
|
During 90 seconds of electrical stimulation
|
|
Neuromuscular efficiency during knee extensors submaximal evoked torque tests
Time Frame: During 90 seconds of electrical stimulation
|
Neuromuscular efficiency of the electrical currents will be evaluated by calculating the current intensity (input parameter or input) by the evoked torque (output parameter) ratio.
|
During 90 seconds of electrical stimulation
|
|
Neuromuscular efficiency during knee extensors maximal evoked torque tests
Time Frame: During 90 seconds of electrical stimulation
|
Neuromuscular efficiency of the electrical currents will be evaluated by calculating the current intensity (input parameter or input) by the evoked torque (output parameter) ratio.
|
During 90 seconds of electrical stimulation
|
|
Neuromuscular efficiency during the fatigue protocol
Time Frame: During 20 minutes of electrical stimulation
|
Neuromuscular efficiency of the electrical currents will be evaluated by calculating the current intensity (input parameter or input) by the evoked torque (output parameter) ratio.
|
During 20 minutes of electrical stimulation
|
|
Clinical efficiency during knee extensors submaximal evoked torque tests
Time Frame: During 90 seconds of electrical stimulation
|
Clinical efficiency of the two electrical currents will be evaluated by calculating the ratio between the evoked torque (output parameter) and the level of discomfort generated.
|
During 90 seconds of electrical stimulation
|
|
Clinical efficiency during knee extensors maximal evoked torque tests
Time Frame: During 90 seconds of electrical stimulation
|
Clinical efficiency of the two electrical currents will be evaluated by calculating the ratio between the evoked torque (output parameter) and the level of discomfort generated.
|
During 90 seconds of electrical stimulation
|
|
Clinical efficiency during the fatigue protocol
Time Frame: During 20 minutes of electrical stimulation
|
Clinical efficiency of the two electrical currents will be evaluated by calculating the ratio between the evoked torque (output parameter) and the level of discomfort generated.
|
During 20 minutes of electrical stimulation
|
|
Muscle Fatigue Index
Time Frame: During 20 minutes of electrical stimulation
|
Characterized by the force decrease after the fatigue protocol, it will be evaluated by dynamometry.
|
During 20 minutes of electrical stimulation
|
|
Fatigue Index from Evoked Torque
Time Frame: During 20 minutes of electrical stimulation
|
Characterized by the decrease of the evoked torque during the fatigue protocol, the fatigue index from evoked torque will be evaluated by dynamometry, and obtained by the analysis of evoked torque curves.
|
During 20 minutes of electrical stimulation
|
|
Total work generated during the fatigue protocol
Time Frame: During 20 minutes of electrical stimulation
|
The torque-time integral of the evoked torque curves during the fatigue protocol will be evaluated.
The sum of the torque curve integral of all evoked contractions during the fatigue protocol will be calculated to determine the total work evoked by each current during the fatigue protocol.
|
During 20 minutes of electrical stimulation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Thickness of the subcutaneous fat layer on the motor point
Time Frame: It will be evaluated during the first evaluation day.
|
Corresponds to the amount of subcutaneous adipose tissue and will be evaluated by ultrasonography.
|
It will be evaluated during the first evaluation day.
|
|
Level of physical activity
Time Frame: 8 minutes. It will be evaluated during the first evaluation day
|
The level of physical activity (PA) of each subject will be assessed by the International Physical Activity Questionnaire (IPAQ).The scores will be assessed by calculating the metabolic equivalents (MET) for each activity level.
Walking score will be achieved by the multiplication of 3.3 METs with the total walking duration in minutes in a week.
Moderate physical activity scores will be achieved by the multiplication of 4.0 METs with the total moderate physical activity duration in minutes in a week.
Vigorous physical activity scores will be achieved by the multiplication of 8.0 METs with the total vigorous physical activity duration in minutes in a week.
Total physical activity MET-minutes/week will be obtained through sum of walking, moderate and vigorous MET minutes/week scores.
Categorical Score will be classified into three levels of physical activity: low, moderate and high.
|
8 minutes. It will be evaluated during the first evaluation day
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 3.064.351
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Young
-
University of Rennes 2CompletedHealthy Young Women | Healthy Young MenFrance
-
University of PalermoCompletedHealthy Subjects | Healthy Participants | Health | Massage Effect | Healthy Young Adults | Myofascial Release | Stretching | Healthy Young PeopleItaly
-
University of PennsylvaniaSuspended
-
National Research Council, SpainOlivenova Health SlCompletedHealthy | YoungSpain
-
Fortaleza UniversityCompleted
-
Heinrich-Heine University, DuesseldorfCompleted
-
University of PalermoCompleted
-
Maastricht University Medical CenterCompleted
-
charbel najemActive, not recruitingHealthy Participants | Healthy Young AdultsLebanon
-
Essilor InternationalNot yet recruiting
Clinical Trials on Pulsed current
-
Western University, CanadaUnknown
-
Western University, CanadaNot yet recruitingHuntington Disease
-
Centro Universitario La SalleRecruiting
-
Diskapi Teaching and Research HospitalRecruiting
-
Diskapi Teaching and Research HospitalActive, not recruitingChronic Pain | Peripheral NeuropathyTurkey
-
Shepherd Center, Atlanta GAThe Craig H. Neilsen FoundationCompletedSpinal Cord Injuries | TetraplegiaUnited States
-
Medical University of South CarolinaWithdrawnTraumatic Brain Injury
-
Braingear Technologies GmbHSpaulding Rehabilitation HospitalUnknownAttention Deficit Disorder With Hyperactivity
-
University of BrasiliaRecruiting
-
Gaziler Physical Medicine and Rehabilitation Education...CompletedTraumatic Brain Injury | Spinal Cord Injuries (SCI) | Pressure InjuriesTurkey (Türkiye)